This $1.5B Mid-Cap ETF Beat Traditional Indexing by 11 Points

Mid-cap stocks are large enough to have survived the startup phase but small enough to grow meaningfully. The challenge is choosing between traditional market-cap weighted indexes or factor-tilted approaches emphasizing profitability and value. John Hancock Multifactor Mid Cap ETF (NYSEARCA:JHMM | JHMM Price Prediction) takes the latter path, screening for size, value, and quality factors within the mid-cap universe.

A Factor Tilt Without the Drama

JHMM tracks the John Hancock Dimensional Mid Cap Index, which includes the 301st through 900th largest U.S. companies by market cap. Rather than weighting purely by size, the index adjusts positions based on three characteristics: smaller market cap within the mid-cap range, attractive price-to-book ratios, and strong operating profit margins.

This generates a portfolio remarkably similar to traditional mid-cap indexes with subtle differences. The fund holds 94% of the same stocks as the Russell Midcap Index with just 31% active share, pursuing factors cautiously. No single position exceeds 1% of assets, spreading risk across industrials, financials, technology, and healthcare. According to ETF Trends, the fund uses a rules-based strategy that emphasizes smaller, more profitable stocks while maintaining sector neutrality.

Performance That Justifies the Premium

JHMM’s factor approach has delivered meaningful outperformance over the long term, with the fund beating traditional mid-cap indexing by 11 percentage points over the past decade. This advantage stems from the fund’s emphasis on profitable, attractively valued companies within the mid-cap space, a strategy that has proven resilient across different market environments including the recent one-year period.

The fund operates with exceptional efficiency for a factor-tilted strategy. Its 0.41% expense ratio positions it between pure indexing and active management, reflecting the additional research and rebalancing required for factor screening. The 12% annual turnover keeps trading costs minimal while the modest dividend yield signals this is primarily designed for capital appreciation rather than income generation.

The Tradeoffs You Accept

Factor investing works over long periods but can underperform during specific market regimes. When low-quality speculative stocks surge, JHMM’s profitability screens will miss those gains. The fund exhibited higher volatility than the Russell Midcap Index since inception due to its smaller-cap tilt.

iShares Core S&P Mid-Cap 400 ETF (NYSEARCA:IJH) provides a compelling low-cost alternative with $88 billion in assets ensuring superior liquidity. The fund’s 0.05% expense ratio undercuts JHMM by 36 basis points annually, and it slightly outperformed over five years despite lacking factor tilts. For investors wanting core mid-cap exposure without betting on factor premiums, IJH delivers the allocation at a fraction of the cost.

Who Should Avoid This Fund

Income-focused retirees seeking steady distributions should look elsewhere given the modest 0.94% yield. Investors with time horizons under five years may not benefit from factor premiums that require full market cycles to emerge.

A Cheaper Alternative Worth Considering

IJH offers similar mid-cap exposure through a traditional market-cap weighted approach without factor tilts. The fund’s massive $88 billion asset base provides superior liquidity for large trades, while its 0.05% annual fee represents one of the lowest costs in the mid-cap category.

Over five years, IJH slightly outperformed JHMM while charging 36 basis points less. For investors wanting straightforward mid-cap exposure without betting on factor premiums, IJH delivers the core allocation at a fraction of the cost.

JHMM works best as a long-term mid-cap holding for investors who believe factor premiums persist, but only if you’re comfortable paying higher fees and accepting periods of factor underperformance.